-
Sort By
-
Newest
-
Newest
-
Oldest
Here’s the fourth instalment of our series on the fascinating ASX cohort of medical device developers. ImpediMed (IPD, 8.1 cents)Market capitalisation: $83.8 millionThree-year total return: -52.7% a yearAnalysts’ consensus target price: 14 cents (Thomson Reuters) You would not know it from the share price performance over the last few years, but Brisbane-based ImpediMed has put…
Australia has followed the US in bouncing back with new sharemarket listings after a hefty slump during much of the first half of the calendar year, at least in terms of the number of initial public offerings (IPOs). In the absence of any mega listings, Australia is still unlikely to break any records in terms…
Rio Tinto Ltd (ASX:RIO) today announced that CEO Jean-Sebastian Jacques, Head of Iron Ore, Chris Salisbury and Head of Corporate Affairs Simone Niven, will be stepping down from their roles following the Juukan Gorge incident. Whilst someone losing their job should never been seen as a positive, is this the first high profile ‘win’ for…
Victorian lockdowns extended, markets remain calm, Labor Day holiday in the US, ASX to open higher
It’s back: US markets down over 4%, dividends the story of the day, a deal with the devil The ASX 200 (ASX:XJO) finished another 0.8% higher, with everything but the IT, materials and utilities sectors adding to the rally. As reporting season comes to an end, dividend payments are driving daily movements with BHP Group…
Market flat for the week, positive lead from the US, manufacturing recovering The ASX 200 finished 0.2% lower for the week, down just 0.1% on Friday, despite a strong US lead. Suncorp Group Ltd (ASX:SUN) was the highlight, beating expectations despite reporting a 33% fall in profit and finishing up 11% for the day. Over…
Retailers at all-time highs, market to open strongly as tech rally continues The ASX 200 (ASX:XJO) fell another 0.8% today, as weaker than expected earnings result and more pessimistic view from the US Federal Reserve impacted sentiment. Most weakness came from the healthcare and financial sectors, representing a substantial portion of the market, however, the…
While more and more Australian investors get comfortable with investing overseas, it’s fair to assume that Latin America is not on most people’s map of the investable universe – “there be dragons,” as the old mariners used to say.
A focus on oil and gas abandonment and implications for the ASX.
Just when you thought it was over. Coronavirus strikes again.